X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-03-01 | MRNA | Afeyan Noubar | Dir | S - Sale | $139.00 | -10,000 | 15,073,952 | 0% | -$1,390,000 | ||||||
2023-02-22 | MRNA | Afeyan Noubar | Dir | S - Sale | $160.35 | -10,000 | 15,083,952 | 0% | -$1,603,500 | ||||||
2023-02-15 | MRNA | Afeyan Noubar | Dir | S - Sale | $173.17 | -10,000 | 15,093,952 | 0% | -$1,731,700 | ||||||
2023-02-08 | MRNA | Afeyan Noubar | Dir | S - Sale | $167.84 | -20,000 | 15,103,952 | 0% | -$3,356,761 | ||||||
2023-01-25 | MRNA | Afeyan Noubar | Dir | S - Sale | $194.33 | -10,000 | 15,123,952 | 0% | -$1,943,300 | ||||||
2023-01-18 | MRNA | Afeyan Noubar | Dir | S - Sale | $200.20 | -10,000 | 15,133,952 | 0% | -$2,002,000 | ||||||
2023-01-11 | MRNA | Afeyan Noubar | Dir | S - Sale | $188.57 | -10,000 | 15,143,952 | 0% | -$1,885,700 | ||||||
2023-01-04 | MRNA | Afeyan Noubar | Dir | S - Sale | $182.15 | -10,000 | 15,153,952 | 0% | -$1,821,500 | ||||||
2022-12-21 | MRNA | Afeyan Noubar | Dir | S - Sale | $201.70 | -10,000 | 15,163,952 | 0% | -$2,017,000 | ||||||
2022-12-14 | MRNA | Afeyan Noubar | Dir | S - Sale | $195.00 | -10,000 | 15,173,952 | 0% | -$1,950,000 | ||||||
2022-12-07 | MRNA | Afeyan Noubar | Dir | S - Sale | $172.16 | -10,000 | 15,183,952 | 0% | -$1,721,600 | ||||||
2022-11-30 | MRNA | Afeyan Noubar | Dir | S - Sale | $173.52 | -10,000 | 15,193,952 | 0% | -$1,735,200 | ||||||
2022-11-23 | MRNA | Afeyan Noubar | Dir | S - Sale | $178.01 | -10,000 | 15,203,952 | 0% | -$1,780,100 | ||||||
2022-11-16 | MRNA | Afeyan Noubar | Dir | S - Sale | $184.25 | -10,000 | 15,213,952 | 0% | -$1,842,500 | ||||||
2022-11-09 | MRNA | Afeyan Noubar | Dir | S - Sale | $162.50 | -10,000 | 15,223,952 | 0% | -$1,625,000 | ||||||
2022-11-02 | MRNA | Afeyan Noubar | Dir | S - Sale | $154.20 | -10,000 | 15,233,952 | 0% | -$1,542,000 | ||||||
2022-10-26 | MRNA | Afeyan Noubar | Dir | S - Sale | $137.25 | -10,000 | 15,243,952 | 0% | -$1,372,500 | ||||||
2022-10-19 | MRNA | Afeyan Noubar | Dir | S - Sale | $132.50 | -10,000 | 15,253,952 | 0% | -$1,325,000 | ||||||
2022-10-12 | MRNA | Afeyan Noubar | Dir | S - Sale | $135.36 | -10,000 | 15,263,952 | 0% | -$1,353,600 | ||||||
2022-10-05 | MRNA | Afeyan Noubar | Dir | S - Sale | $122.40 | -10,000 | 15,273,952 | 0% | -$1,224,000 | ||||||
2022-09-28 | MRNA | Afeyan Noubar | Dir | S - Sale | $123.58 | -10,000 | 15,283,952 | 0% | -$1,235,800 | ||||||
2022-09-21 | MRNA | Afeyan Noubar | Dir | S - Sale | $130.37 | -10,000 | 15,293,952 | 0% | -$1,303,700 | ||||||
2022-09-14 | MRNA | Afeyan Noubar | Dir | S - Sale | $134.00 | -10,000 | 15,303,952 | 0% | -$1,340,000 | ||||||
2022-09-07 | MRNA | Afeyan Noubar | Dir | S - Sale | $129.68 | -10,000 | 15,313,952 | 0% | -$1,296,800 | ||||||
2022-08-31 | MRNA | Afeyan Noubar | Dir | S - Sale | $136.95 | -10,000 | 15,323,952 | 0% | -$1,369,500 | ||||||
2022-08-17 | MRNA | Afeyan Noubar | Dir | S - Sale | $165.24 | -10,000 | 15,333,952 | 0% | -$1,652,400 | ||||||
2022-08-10 | MRNA | Afeyan Noubar | Dir | S - Sale | $174.09 | -10,000 | 15,343,952 | 0% | -$1,740,900 | ||||||
2022-08-03 | MRNA | Afeyan Noubar | Dir | S - Sale | $167.99 | -10,000 | 15,353,952 | 0% | -$1,679,900 | ||||||
2022-07-27 | MRNA | Afeyan Noubar | Dir | S - Sale | $161.00 | -10,000 | 15,363,952 | 0% | -$1,610,000 | ||||||
2022-07-20 | MRNA | Afeyan Noubar | Dir | S - Sale | $167.00 | -10,000 | 15,373,952 | 0% | -$1,670,000 | ||||||
2022-07-13 | MRNA | Afeyan Noubar | Dir | S - Sale | $168.88 | -10,000 | 15,383,952 | 0% | -$1,688,800 | ||||||
2022-07-13 | MRNA | Afeyan Noubar | Dir | S - Sale | $168.88 | -10,000 | 15,383,952 | 0% | -$1,688,800 | ||||||
2022-07-06 | MRNA | Afeyan Noubar | Dir | S - Sale | $154.85 | -10,000 | 15,393,952 | 0% | -$1,548,500 | ||||||
2022-06-29 | MRNA | Afeyan Noubar | Dir | S - Sale | $140.47 | -10,000 | 15,403,952 | 0% | -$1,404,700 | ||||||
2022-06-22 | MRNA | Afeyan Noubar | Dir | S - Sale | $127.69 | -10,000 | 15,413,952 | 0% | -$1,276,900 | ||||||
2022-06-08 | MRNA | Afeyan Noubar | Dir | S - Sale | $147.47 | -10,000 | 15,423,952 | 0% | -$1,474,700 | ||||||
2022-06-01 | MRNA | Afeyan Noubar | Dir | S - Sale | $146.31 | -10,000 | 15,433,952 | 0% | -$1,463,100 | ||||||
2022-05-25 | MRNA | Afeyan Noubar | Dir | S - Sale | $130.80 | -10,000 | 15,443,952 | 0% | -$1,308,000 | ||||||
2022-05-18 | MRNA | Afeyan Noubar | Dir | S - Sale | $138.38 | -10,000 | 15,453,952 | 0% | -$1,383,800 | ||||||
| M | 2022-05-11 | MRNA | Afeyan Noubar | Dir | S - Sale | $131.79 | -310,000 | 19,510,689 | -2% | -$40,855,186 | |||||
| M | 2021-03-29 | MRNA | Afeyan Noubar | Dir | S - Sale | $121.43 | -3,752,805 | 22,682,719 | -14% | -$455,692,554 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |